Addex Therapeutics Ltd
SIX:ADXN
Addex Therapeutics Ltd
Net Income
Addex Therapeutics Ltd
Net Income Peer Comparison
Competitive Net Income Analysis
Latest Figures & CAGR of Competitors
Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Addex Therapeutics Ltd
SIX:ADXN
|
Net Income
-CHf10.6m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Net Income
-CHf54.6m
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Net Income
-$217.1m
|
CAGR 3-Years
18%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Net Income
CHf10.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
SIX:IDIA
|
Net Income
-CHf297.9m
|
CAGR 3-Years
13%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Net Income
-CHf13.3m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
See Also
What is Addex Therapeutics Ltd's Net Income?
Net Income
-10.6m
CHF
Based on the financial report for Dec 31, 2023, Addex Therapeutics Ltd's Net Income amounts to -10.6m CHF.
What is Addex Therapeutics Ltd's Net Income growth rate?
Net Income CAGR 5Y
-45%
Over the last year, the Net Income growth was 49%. The average annual Net Income growth rates for Addex Therapeutics Ltd have been 6% over the past three years , -45% over the past five years .